Context Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 7.42 M | $14.54 M | 0.00% | 9.22% |
| NEXTECH INVEST LTD. | 11/14/2024 | 7.42 M | $14.54 M | 0.00% | 9.22% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 7.42 M | $14.54 M | -0.03% | 9.22% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 6.93 M | $13.59 B | -6.53% | 8.62% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 5.41 M | $10.61 M | 4.84% | 6.72% |
| VANGUARD GROUP INC | 11/13/2024 | 3.74 M | $7.34 M | -16.82% | 4.65% |
| BLACKSTONE INC. | 11/14/2024 | 2.44 M | $4.78 M | 32.72% | 3.03% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.94 M | $3.79 M | 0.00% | 2.40% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 1.85 M | $3.69 M | 100.00% | 2.30% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2024 | 1.76 M | $3.44 M | -6.82% | 2.18% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 1.66 M | $3.26 M | -14.04% | 2.07% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.36 M | $2.67 M | 100.00% | 1.69% |
| SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.33 M | $2.60 M | 0.00% | 1.65% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 1.32 M | $2.59 M | -18.40% | 1.64% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2024 | 1.29 M | $2.53 B | 0.00% | 1.60% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 848,970 | $1.66 M | 100.00% | 1.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 575,899 | $1.13 M | -6.84% | 0.72% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 373,835 | $732,717 | -42.06% | 0.46% |
| UBS OCONNOR LLC | 11/14/2024 | 308,758 | $605,166 | 5.11% | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 143,883 | $282,011 | 100.00% | 0.18% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 125,852 | $247,000 | 0.00% | 0.16% |
| STATE STREET CORP | 11/14/2024 | 111,907 | $219,338 | 21.50% | 0.14% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 109,655 | $214,924 | 1.18% | 0.14% |
| MILL CREEK CAPITAL ADVISORS, LLC | 11/06/2024 | 104,631 | $205,077 | 0.00% | 0.13% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 103,405 | $202,674 | 100.00% | 0.13% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 66,000 | $129,360 | 1.23% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 54,211 | $106,254 | 100.00% | 0.07% |
| 11/13/2024 | 52,792 | $103,472 | 100.00% | 0.07% | |
| Y-INTERCEPT (HONG KONG) LTD | 11/15/2024 | 45,635 | $89,445 | 100.00% | 0.06% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 43,200 | $84,672 | 100.00% | 0.05% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 10/24/2024 | 36,000 | $70,560 | 0.00% | 0.04% |
| CAXTON CORP | 11/14/2024 | 18,403 | $36,071 | 0.00% | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 13,844 | $27,134 | 0.00% | 0.02% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 10,192 | $19,976 | -5.42% | 0.01% |
| CERITY PARTNERS LLC | 11/12/2024 | 10,000 | $19,600 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 7,155 | $14,024 | 100.00% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 1,717 | $3,365 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 500 | $980 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 10/15/2024 | 200 | $392 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 173 | $339 | 100.00% | 0.00% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
Context Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Context Therapeutics Inc.. The most heavily invested institutionals were:
Nextech Invest Ltd.: 7.42 M
Deep Track Capital, LP: 7.42 M
Avidity Partners Management LP: 7.42 M
GREAT POINT PARTNERS LLC: 6.93 M
Blue Owl Capital Holdings LP: 5.41 M
VANGUARD GROUP INC: 3.74 M
70.43% of Context Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 57.48 M shares in the last 24 months. This purchase volume represents approximately $71.27 M in transactions.